Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27828481

CC(C)(C)OC=O.CCC1CC(N)CC(CC)N1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27746413 0.85 TDP1 (0.32) TDP1
Tert-Butyl Formate SCHEMBL27847386 0.80 TDP1 (0.43) TDP1
Tert-Butyl Formate SCHEMBL27847387 0.80 TDP1 (0.43) TDP1
SCHEMBL13620623 0.78 MGAM (0.31)
SCHEMBL7521682 0.78 MGAM (0.31)
SCHEMBL27767233 0.77
Tert-Butyl Formate SCHEMBL27713287 0.72 TDP1 (0.56) TDP1
Tert-Butyl Formate SCHEMBL28793951 0.71 GRIN2B (0.37)
Tert-Butyl Formate SCHEMBL28149280 0.70 TDP1 (0.59) TDP1
Tert-Butyl Formate SCHEMBL28758511 0.70 TDP1 (0.43) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101910150-B 4-benzylamino-1-carboxyacylpiperidine derivatives as CETP inhibitors useful in the treatment of diseases such as hyperlipidemia or arteriosclerosis NOVARTIS AG 2013-09-18 CN disclosed
CN-101910150-A 4-benzylamino-1-carboxyacylpiperidine derivatives as CETP inhibitors useful in the treatment of diseases such as hyperlipidemia or arteriosclerosis NOVARTIS AG 2010-12-08 CN disclosed